A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...

Florida-based biotech company Soilcea developed CarriCea T1, a Carrizo orange variety that is resistant to HLB, also known as ...

A child known publicly as Baby KJ was celebrated onstage at the twelfth Breakthrough Prize ceremony in Santa Monica last ...

Intellia Therapeutics’ in vivo CRISPR therapy, lonvo-z, met its primary goal in a Phase III hereditary angioedema trial, cutting attacks by 87% versus placebo. All treated patients avoided long-term ...

Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

Researchers have developed a modified CRISPR gene-editing tool with potential to silence the extra chromosome causing Down ...

KAIST and international collaborators have developed a CRISPR-based 'kinetic barcoding' method that distinguishes multiple ...

(Nanowerk News) In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy ...

National Institutes of Health (NIH) released the following: A National Institutes of Health (NIH)-funded research team has ...

Torie Bosch is the First Opinion editor at STAT. Celena Lozano’s son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price is up, but its Casgevy sales partner, CRISPR Therapeutics (NASDAQ: CRSP), is the real buy for long-term investors. Shares of Vertex, a biotech based ...